Biolife Sciences (BLFE)
OTHER OTC:BLFE
BLFE Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EST
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume40.00
Average Volume (3M)N/A
Market Cap
$4.83K
Enterprise Value$311.53K
Total Cash (Recent Filing)$16.00
Total Debt (Recent Filing)$398.00
Price to Earnings (P/E)―
Beta-17.34
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding4,829,364,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-84.85
Price to Sales (P/S)142.12
P/FCF Ratio-66.09
Enterprise Value/Market Cap64.51
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-1.19
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BLFE FAQ
What was Biolife Sciences’s price range in the past 12 months?
Currently, no data Available
What is Biolife Sciences’s market cap?
Biolife Sciences’s market cap is $4.83K.
When is Biolife Sciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Biolife Sciences’s earnings last quarter?
Currently, no data Available
Is Biolife Sciences overvalued?
According to Wall Street analysts Biolife Sciences’s price is currently Overvalued.
Does Biolife Sciences pay dividends?
Biolife Sciences does not currently pay dividends.
What is Biolife Sciences’s EPS estimate?
Biolife Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biolife Sciences have?
Biolife Sciences has 4,829,364,000 shares outstanding.
What happened to Biolife Sciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biolife Sciences?
Currently, no hedge funds are holding shares in BLFE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Biolife Sciences
BioLife Sciences Corp. specializes in the creation, licensing, and distribution of both antibacterial solutions and advanced non-contact human temperature screening technologies. Its diverse product portfolio includes sanitizing wipes, ultraviolet (UV) sterilization equipment, professional electrostatic disinfection services, specialized anti-microbial fabrics, and innovative touch-free vending or marketplace systems. The company, which was established in 2018, operates from its base in Mississauga, Canada.
Scinai Immunotherapeutics
―
Universe Pharmaceuticals
―
Akanda Corp
―
CDT Equity
―
Virax Biolabs Group Ltd. Class A
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---